IP Library Granted Patent US 6,974,872
Granted Patent B2
US 6,974,872 · App. 10/212,854 · Granted Dec 13, 2005

Process for production of piperidine derivatives

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,974,872
App. No.
10/212,854
Granted
Dec 13, 2005
Kind
B2
Abstract

The present invention discloses processes for preparing piperidine derivative compounds of the formulae: wherein n is 0 or 1; R 1 is hydrogen or hydroxy; R 2 is hydrogen; or, when n is 0, R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 , provided that when n is 1, R 1 and R 2 are each hydrogen; R 3 is —COOH or —COOR 4 ; R 4 is an alkyl or aryl moiety; A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents.

Claims (282)

1. A process of preparing a piperidine derivative compound of the formula:

wherein

n is 0 or 1;

R 1 is hydrogen or hydroxy;

R 2 is hydrogen;

or, when n is 0, R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 , provided that when n is 1, R 1 and R 2 are each hydrogen;

R 3 is —COOH or —COOR 4 ;

R 4 is an alkyl or aryl moiety;

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents,

said process comprising:

providing a regioisomer of the following formula:

wherein

Z is

m is an integer from 1 to 6;

Q and O;

Y is selected from the group consisting of O, S, and NR 5 ;

X 3 is halogen, OR 15 , SR 15 , NR 15 R 16 , OSO 2 R 15 , or NHSO 2 R 15 ;

R 6 and R 7 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, an aryl moiety, OR 8 , SR 8 , and NR 8 R 9 ; and

R 5 , R 8 , R 9 , R 15 , and R 16 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

and

converting the regioisomer to the piperidine derivative compound with a piperidine compound.

2. A process according to claim 1 , wherein said providing the regioisomer comprises:

acylating an α,α-disubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formulae:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the regioisomer.

3. A process according to claim 2 , further comprising:

reacting an α,α-diunsubstituted-methylbenzene derivative having the formula:

with a methylating agent under conditions effective to produce the α,α-disubstituted-methylbenzene derivative.

4. A process according to claim 3 , wherein Z has the formula:

and further comprising

reacting an α,α-diunsubstituted benzylic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the α,α-diunsubstituted-methylbenzene derivative.

5. A process according to claim 2 wherein Z has the formula:

and further comprising:

reacting an α,α-disubstituted benzylic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the α,α-disubstituted-methylbenzene derivative.

6. A process according to claim 1 , wherein said providing the regioisomer comprises:

reacting a 4-(α,α-disubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the regioisomer.

7. A process according to claim 6 further comprising:

reacting a 4-(α,α-diunsubstituted)-toluic acid derivative having the formula:

with a methylating agent under conditions effective to produce the 4-(α,α-disubstituted)-toluic acid derivative.

8. A process according to claim 7 , wherein Z has the formula:

and further comprising

reacting a 4-(α-carboxy-α,α-diunsubstituted)-toluic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the 4-(α,α-diunsubstituted)-toluic acid derivative.

9. A process according to claim 6 , wherein Z has the formula:

and further comprising:

reacting a 4-(α-carboxy-α,α-disubstituted)-toluic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the 4-(α,α-disubstituted)-toluic acid derivative.

10. A process according to claim 1 , wherein said providing the regioisomer comprises:

providing an α,α-diunsubstituted regioisomer precursor having the formula:

and

methylating the α,α-diunsubstituted regioisomer precursor under conditions effective to produce the regioisomer.

11. A process according to claim 10 , wherein said providing the α,α-diunsubstituted regioisomer precursor comprises:

acylating an α,α-diunsubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formulae:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the α,α-diunsubstituted regioisomer precursor.

12. A process according to claim 10 , wherein said providing the α,α-diunsubstituted regioisomer precursor comprises:

reacting a 4-(α,α-diunsubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the α,α-diunsubstituted regioisomer precursor.

13. A process according to claim 1 , further comprising:

reducing the piperidine derivative compound under conditions effective to form a hydroxylated piperidine derivative compound of the formula:

14. A process according to claim 1 , wherein m is an integer from 2 to 4.

15. A process of preparing a piperidine derivative compound of the formula:

wherein

n is 0 or 1;

R 1 is hydrogen or hydroxy;

R 2 is hydrogen;

or, when n is 0, R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 , provided that when n is 1, R 1 and R 2 are each hydrogen;

R 3 is —COOH or —COOR 4 ;

R 4 is an alkyl or aryl moiety;

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents,

said process comprising:

providing a regioisomer of the following formula:

wherein

Z is

m is an integer from 1 to 6;

Q is S;

Y is selected from the group consisting of O, S, and NR 5 ;

X 3 is halogen, OR 15 , SR 15 , NR 15 R 16 , OSO 2 R 15 , or NHSO 2 R 15 ;

R 6 and R 7 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, an aryl moiety, OR 8 , SR 8 , and NR 8 R 9 ; and

R 5 , R 8 , R 9 , R 15 , and R 16 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety and

converting the regioisomer to the piperidine derivative compound with a piperidine compound.

16. A process according to claim 15 , wherein said providing the regioisomer comprises:

acylating an α,α-disubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formulae:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the regioisomer.

17. A process according to claim 16 , further comprising:

reacting an α,α-diunsubstituted-methylbenzene derivative having the formula:

with a methylating agent under conditions effective to produce the α,α-disubstituted-methylbenzene derivative.

18. A process according to claim 17 , wherein Z has the formula:

and further comprising

reacting an α,α-diunsubstituted benzylic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the α,α-diunsubstituted-methylbenzene derivative.

19. A process according to claim 16 , wherein Z has the formula:

and further comprising:

reacting an α,α-disubstituted benzylic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the α,α-disubstituted-methylbenzene derivative.

20. A process according to claim 15 , wherein said providing the regioisomer comprises:

reacting a 4-(α,α-disubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the regioisomer.

21. A process according to claim 20 further comprising:

reacting a 4-(α,α-diunsubstituted)-toluic acid derivative having the formula:

with a methylating agent under conditions effective to produce the 4-(α,α-disubstituted)-toluic acid derivative.

22. A process according to claim 21 , wherein Z has the formula:

and further comprising

reacting a 4-(α-carboxy-α,α-diunsubstituted)-toluic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

 H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the 4-(α,α-diunsubstituted)-toluic acid derivative.

23. A process according to claim 20 , wherein Z has the formula:

and further comprising:

reacting a 4-(α-carboxy-α,α-disubstituted)-toluic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the 4-(α,α-disubstituted)-toluic acid derivative.

24. A process according to claim 15 , wherein said providing the regioisomer comprises:

providing an α,α-diunsubstituted regioisomer precursor having the formula:

and

methylating the α,α-diunsubstituted regioisomer precursor under conditions effective to produce the regioisomer.

25. A process according to claim 24 , wherein said providing the α,α-diunsubstituted regioisomer precursor comprises:

acylating an α,α-diunsubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formulae:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the α,α-diunsubstituted regioisomer precursor.

26. A process according to claim 24 , wherein said providing the α,α-diunsubstituted regioisomer precursor comprises:

reacting a 4-(α,α-diunsubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the α,α-diunsubstituted regioisomer precursor.

27. A process according to claim 15 , further comprising:

reducing the piperidine derivative compound under conditions effective to form a hydroxylated piperidine derivative compound of the formula:

28. A process according to claim 15 , wherein m is an integer from 2 to 4.

29. A process of preparing a piperidine derivative compound of the formula:

wherein

n is 0 or 1;

R 1 is hydrogen or hydroxy;

R 2 is hydrogen;

or, when n is 0, R 1 and R 2 taken together form a second bond between the carbon atoms bearing R 1 and R 2 , provided that when n is 1, R 1 and R 2 are each hydrogen;

R 3 is —COOH or —COOR 4 ;

R 4 is an alkyl or aryl moiety;

A, B, and D are the substituents of their rings, each of which may be different or the same, and are selected from the group consisting of hydrogen, halogens, alkyl, hydroxy, alkoxy, and other substituents,

said process comprising:

providing a regioisomer of the following formula:

wherein

Z is

m is an integer from 1 to 6;

Q is R 5 ;

Y is selected from the group consisting of O, S, and NR 5 ;

X 3 is halogen, OR 15 , SR 15 , NR 15 R 16 , OSO 2 R 15 , or NHSO 2 R 15 ;

R 6 and R 7 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, an aryl moiety, OR 8 , SR 8 , and NR 8 R 9 ; and

R 5 , R 8 , R 9 , R 15 , and R 16 are the same or different and are selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety and

converting the regioisomer to the piperidine derivative compound with a piperidine compound.

30. A process according to claim 29 , wherein said providing the regioisomer comprises:

acylating an α,α-disubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formulae:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the regioisomer.

31. A process according to claim 30 , further comprising: -reacting an α,α-diunsubstituted-methylbenzene derivative having the formula:

with a methylating agent under conditions effective to produce the α,α-disubstituted-methylbenzene derivative.

32. A process according to claim 31 , wherein Z has the formula:

and further comprising

reacting an α,α-diunsubstituted benzylic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the α,α-diunsubstituted-methylbenzene derivative.

33. A process according to claim 30 wherein Z has the formula:

and further comprising:

reacting an α,α-disubstituted benzylic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the α,α-disubstituted-methylbenzene derivative.

34. A process according to claim 29 , wherein said providing the regioisomer comprises:

reacting a 4-(α,α-disubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the regioisomer.

35. A process according to claim 34 further comprising:

reacting a 4-(α,α-diunsubstituted)-toluic acid derivative having the formula:

with a methylating agent under conditions effective to produce the 4-(α,α-disubstituted)-toluic acid derivative.

36. A process according to claim 35 , wherein Z has the formula:

and further comprising

reacting a 4-(α-carboxy-α,α-diunsubstituted)-toluic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

 H 2 N—(CR 6 R 7 ) m -O-H

under conditions effective to produce the 4-(α,α-diunsubstituted)-toluic acid derivative.

37. A process according to claim 34 , wherein Z has the formula:

and further comprising:

reacting a 4-(α-carboxy-α,α-disubstituted)-toluic acid derivative having the formula:

with an aminoalkyl derivative having the formula:

H 2 N—(CR 6 R 7 ) m -Q-H

under conditions effective to produce the 4-(α,α-disubstituted)-toluic acid derivative.

38. A process according to claim 29 , wherein said providing the regioisomer comprises:

providing an α,α-diunsubstituted regioisomer precursor having the formula:

and

methylating the α,α-diunsubstituted regioisomer precursor under conditions effective to produce the regioisomer.

39. A process according to claim 38 , wherein said providing the α,α-diunsubstituted regioisomer precursor comprises:

acylating an α,α-diunsubstituted-methylbenzene derivative having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

with a compound having the formulae:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

under conditions effective to produce the α,α-diunsubstituted regioisomer precursor.

40. A process according to claim 38 , wherein said providing the α,α-diunsubstituted regioisomer precursor comprises:

reacting a 4-(α,α-diunsubstituted)-toluic acid derivative having the formula:

wherein

X 2 is hydrogen; a halogen; an alkali metal oxide; a moiety having the formula —OR 10 ; a moiety having the formula —SR 10 ; or an amine; and

R 10 is selected from the group consisting of hydrogen, an alkyl moiety, and an aryl moiety

with a compound having the formula:

wherein

X 1 is a halogen, trialkyl or triaryl tin, trialkyl or triaryl borate, trialkyl silicon, alkylhalo silicon, a substituted sulfonic ester, or substituents useful in organometallic coupling reactions

under conditions effective to produce the α,α-diunsubstituted regioisomer precursor.

41. A process according to claim 29 , further comprising:

reducing the piperidine derivative compound under conditions effective to form hydroxylated piperidine derivative compound of the formula:

42. A process according to claim 29 , wherein m is an integer from 2 to 4.

43. A process according to claim 29 , wherein R 5 is hydrogen.

44. A process according to claim 29 , wherein R 5 is a branched or unbranched C1-C7 alkyl group.

45. A process according to claim 29 , wherein R 5 is an aryl or heteroaryl group.

Assignments (14)
ASSIGNMENT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY, RECORDED ON SEPTEMBER 1, 2017, AT REEL/FRAME 043746/0621 Recorded Mar 17, 2025
From: BARCLAYS BANK PLC, AS EXISTING AGENT
To: APOLLO ADMINISTRATIVE AGENCY LLC, AS SUCCESSOR AGENT
Reel/Frame 070531/0279 →
SECURITY INTEREST Recorded Sep 6, 2021
From: CURIA GLOBAL, INC. (FKA ALBANY MOLECULAR RESEARCH, INC.); CURIA MASSACHUSETTS, INC. (FKA AMRI BURLINGTON, INC.); CURIA WISCONSIN, INC. (FKA CEDARBURG PHARMACEUTICALS, INC.); CURIA INDIANA, LLC (FKA AMRI SSCI, LLC); CURIA NEW MEXICO, LLC (FKA OSO BIOPHARMACEUTICALS MANUFACTURING, LLC); CURIA IP HOLDINGS, LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 057423/0665 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2020
From: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
Reel/Frame 054252/0687 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 7541537 PREVIOUSLY RECORDED AT REEL: 034045 FRAME: 0951. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded Aug 14, 2018
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 046796/0352 →
FIRST LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC-BY ITS SOLE MEMBER: ALO ACQUISITION LLC
To: BARCLAYS BANK, PLC AS COLLATERAL AGENT
Reel/Frame 043746/0621 →
SECOND LIEN SECURITY AGREEMENT Recorded Sep 1, 2017
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; CEDARBURG PHARMACEUTICALS, INC.; EUTICALS INC.; OSO BIOPHARMACEUTICALS MANUFACTURING LLC-BY ITS SOLE MEMBER:ALO ACQUISITION LLC
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 043746/0657 →
RELEASE OF SECURITY INTEREST Recorded Aug 31, 2017
From: BARCLAYS BANK PLC, AS COLLATERAL AGENT
To: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC; AMRI SSCI, LLC; EUTICALS INC.
Reel/Frame 043742/0085 →
SECURITY INTEREST Recorded Oct 24, 2014
From: ALBANY MOLECULAR RESEARCH, INC.; ALO ACQUISITION LLC; AMRI BURLINGTON, INC.; AMRI RENSSELAER, INC.; CEDARBURG PHARMACEUTICALS, INC.; OSO BIOPHARMACEUTICALS MANUFACTURING, LLC
To: BARCLAYS BANK PLC, AS THE COLLATERAL AGENT
Reel/Frame 034045/0951 →
RELEASE OF SECURITY INTEREST Recorded Jul 9, 2014
From: WELLS FARGO
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 033283/0357 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI BURLINGTON, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI RENESSELAER, INC.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 028078/0227 →
TERMINATION Recorded Apr 19, 2012
From: BANK OF AMERICA, N.A.
To: ALBANY MOLECULAR RESEARCH, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.; AMRI RENESSELAER, INC.
Reel/Frame 028072/0335 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jun 6, 2011
From: ALBANY MOLECULAR RESEARCH, INC.; AMRI RENSSELAER, INC.; AMRI BOTHELL RESEARCH CENTER, INC.; AMRI BURLINGTON, INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026397/0001 →
MERGER Recorded Feb 8, 2010
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 023905/0317 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2009
From: AMR TECHNOLOGY, INC.
To: ALBANY MOLECULAR RESEARCH, INC.
Reel/Frame 022092/0512 →